Exploratory biomarker analysis in the PH 3 ECHELON‐1 study: Worse outcome with ABVD in patients with elevated baseline levels of SCD30 and TARC Meeting Abstract
| Authors: | Radford, J.; Connors, J. M.; Younes, A.; Gallamini, A.; Ansell, S. M.; Kim, W. S.; Cheong, J.; Flinn, I.; Kalakonda, N.; Kaminski, M.; Pettengell, R.; Onsum, M.; Josephson, N.; Kuroda, S.; Liu, R.; Miao, H.; Gautam, A.; Trepicchio, W. L.; Sureda, A. |
| Abstract Title: | Exploratory biomarker analysis in the PH 3 ECHELON‐1 study: Worse outcome with ABVD in patients with elevated baseline levels of SCD30 and TARC |
| Meeting Title: | 15th International Conference on Malignant Lymphoma |
| Journal Title: | Hematological Oncology |
| Volume: | 37 |
| Issue: | Suppl. 2 |
| Meeting Dates: | 2019 Jun 18-22 |
| Meeting Location: | Lugano, Switzerland |
| ISSN: | 0278-0232 |
| Publisher: | Wiley Blackwell |
| Date Published: | 2019-06-01 |
| Start Page: | 290 |
| End Page: | 291 |
| Language: | English |
| ACCESSION: | 137029564 |
| DOI: | 10.1002/hon.99_2630 |
| PROVIDER: | EBSCOhost |
| PROVIDER: | cin20 |
| PUBMED: | 31187525 |
| DOI/URL: | |
| Notes: | Meeting abstract: 235 -- Accession Number: 137029564 -- Entry Date: In Process -- Revision Date: 20190620 -- Publication Type: Article -- Supplement Title: Jun2019 Supplement S2 -- Journal Subset: Biomedical; Europe; Peer Reviewed; UK & Ireland -- NLM UID: 8307268. -- Source: cin20 |
